OW 2025 4 - 7 November 2025

Effect of semaglutide 2.4 mg in Chinese adults with overweight or obesity (BMI ≥24 or ≥28): STEP 12

Authors :

Lixin Guo¹; Xiaolei Bao²; Kristoffer Jensen Kolnes³; Christian Laugesen³; Yibing Lu⁴; Bifen Luo²; Guoyue Yuan⁵; Robert Kushner⁶

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Download poster (.pdf)

Keywords

Obesity

Congress oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)